ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

IQAI Iq-ai Limited

1.60
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Iq-ai Limited LSE:IQAI London Ordinary Share JE00BD4H0R42 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.60 1.50 1.70 1.60 1.55 1.60 326,452 14:24:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Florists 609k -624k -0.0028 -5.71 3.55M
Iq-ai Limited is listed in the Florists sector of the London Stock Exchange with ticker IQAI. The last closing price for Iq-ai was 1.60p. Over the last year, Iq-ai shares have traded in a share price range of 0.975p to 5.30p.

Iq-ai currently has 221,709,789 shares in issue. The market capitalisation of Iq-ai is £3.55 million. Iq-ai has a price to earnings ratio (PE ratio) of -5.71.

Iq-ai Share Discussion Threads

Showing 8651 to 8671 of 9150 messages
Chat Pages: Latest  354  353  352  351  350  349  348  347  346  345  344  343  Older
DateSubjectAuthorDiscuss
27/10/2023
11:30
I agree F there needs to be a cross section of views posted to encourage debate. Many of us hold and trade the same stock but that does not prevent us from being negative or positive as the case maybe at any given time, or question RNS etc.
clocktower
27/10/2023
11:03
Only two MM on offer at 4.4p
clocktower
27/10/2023
11:02
Clearly most followers of this stock must be posting on other sites these days, I say that because of the amount of support there has been over the last couple of months there has been very few serious PI's that have posted on either thread.
clocktower
27/10/2023
10:58
you get the feeling that one revenue generating RNS and the share price will fly
howdlep
27/10/2023
10:18
The bid is 500,000 for 4.125p
festario
27/10/2023
10:16
Oh, there's my answer. None left at 4.4p
festario
27/10/2023
10:05
Anyone got level 2, so we can see how many are left on the offer at the 4.3p level?
festario
27/10/2023
07:44
Yes, thanks for the post howdlep, a very good post and there is a great level of support, so it should go places but still worth trying to ride the waves, so far so good but unless there was really outstanding news 5p is my target this time.

Still a great long term hold if even you want to put a couple of thousand pounds worth in the portfolio impo.

clocktower
27/10/2023
06:53
I really appreciate you posting that, it does help to make us understand what is happening and what it hopefully is leading to. I can't use LSE, but maybe I should give it another whirl?
festario
26/10/2023
13:26
500k for 4.04p Or 3.8p for a million
festario
26/10/2023
11:41
I'm bid 4.04p now for 500,000 shares
festario
26/10/2023
08:36
Yes, it's 4.02p to sell 250,000
festario
26/10/2023
08:27
Never completely out F but I add as and when, and the other day I said I thought it offered value. :-)

Looking good again today.

clocktower
25/10/2023
23:41
Thanks spurs, getting interesting. Thought the review would take longer to start. They can apply for their $100M voucher in less than 60 days then as its once the process starts not once they get a decision.

"In addition, the FDA recently granted orphan drug designation (ODD) status for GaM in the treatment of another rare cancer, atypical teratoid rhabdoid tumor (ATRT), which was based on yet another pre-clinical study conducted in the Schmainda lab at MCW. This is the second ODD for GaM this year. We are currently working on an application for FDA Fast Track Designation. This is a program the FDA uses to fosters accelerated development and review of drugs that treat conditions with an unmet clinical need. We are targeting a submission by the end of October.

Once that submission is under review, and to leverage our ODD designation for pediatric brain tumors (GBM and ATRT), we will apply for a Rare Pediatric Disease Priority Review Voucher (RPD-PRV). Like the Fast Track program, RPD-PRV is another accelerated pathway authorised by the FDA which offers incentives for development and approval for promising drugs. If IB is successful in applying for an RPD-PRV, the vouchers can be transferred (sold) to other companies and the trading price of a PRV, per KIDS V CANCER (givekidsachanceact.org) , is averaging $100 million."

bad gateway
25/10/2023
19:34
IQAI TWEET!

Another step forward in bringing innovative therapies to patients with #GBM - we submitted a Fast Track designation request to the FDA for oral gallium maltolate. Fast Track is an expedited approval pathway for agents that treat serious conditions & address unmet clinical needs.

How long is Fast Track FDA approval?

within sixty days

Fast Track designation must be requested by the drug company. The request can be initiated at any time during the drug development process. FDA will review the request and make a decision within sixty days based on whether the drug fills an unmet medical need in a serious condition.

Not long to wait!

spurs90
25/10/2023
12:25
Now its 3.99p for 500,000 shares Or 3.82p for 800,000
festario
25/10/2023
10:23
Are you back in Clockster? It never reached your 3p, but you could have grabbed 3.5p at best.
festario
25/10/2023
10:18
Solid move up again, maybe hit 5p again.
clocktower
25/10/2023
09:56
Price to sell 500k shares is 3.99p A very nice platform for another move up.
festario
24/10/2023
12:51
Are you saying the 560k is yours clocky?
spurs90
24/10/2023
12:45
Some value around today here I noticed.
clocktower
Chat Pages: Latest  354  353  352  351  350  349  348  347  346  345  344  343  Older

Your Recent History

Delayed Upgrade Clock